Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 39

1.

Movements of HIV-1 genomic RNA-APOBEC3F complexes and PKR reveal cytoplasmic and nuclear PKR defenses and HIV-1 evasion strategies.

Marin M, Golem S, Kozak SL, Kabat D.

Virus Res. 2016 Feb 2;213:124-139. doi: 10.1016/j.virusres.2015.11.023. Epub 2015 Nov 25.

2.

RRE-dependent HIV-1 Env RNA effects on Gag protein expression, assembly and release.

López CS, Sloan R, Cylinder I, Kozak SL, Kabat D, Barklis E.

Virology. 2014 Aug;462-463:126-34. doi: 10.1016/j.virol.2014.05.019. Epub 2014 Jun 25.

3.
4.

Evidence that ecotropic murine leukemia virus contamination in TZM-bl cells does not affect the outcome of neutralizing antibody assays with human immunodeficiency virus type 1.

Platt EJ, Bilska M, Kozak SL, Kabat D, Montefiori DC.

J Virol. 2009 Aug;83(16):8289-92. doi: 10.1128/JVI.00709-09. Epub 2009 May 27.

6.

The anti-HIV-1 editing enzyme APOBEC3G binds HIV-1 RNA and messenger RNAs that shuttle between polysomes and stress granules.

Kozak SL, Marin M, Rose KM, Bystrom C, Kabat D.

J Biol Chem. 2006 Sep 29;281(39):29105-19. Epub 2006 Aug 3.

7.

Regulated production and anti-HIV type 1 activities of cytidine deaminases APOBEC3B, 3F, and 3G.

Rose KM, Marin M, Kozak SL, Kabat D.

AIDS Res Hum Retroviruses. 2005 Jul;21(7):611-9.

PMID:
16060832
8.

Transcriptional regulation of APOBEC3G, a cytidine deaminase that hypermutates human immunodeficiency virus.

Rose KM, Marin M, Kozak SL, Kabat D.

J Biol Chem. 2004 Oct 1;279(40):41744-9. Epub 2004 Aug 5.

9.

The viral infectivity factor (Vif) of HIV-1 unveiled.

Rose KM, Marin M, Kozak SL, Kabat D.

Trends Mol Med. 2004 Jun;10(6):291-7. Review.

PMID:
15177194
10.

HIV-1 Vif protein binds the editing enzyme APOBEC3G and induces its degradation.

Marin M, Rose KM, Kozak SL, Kabat D.

Nat Med. 2003 Nov;9(11):1398-403. Epub 2003 Oct 5.

11.

Implication of the lymphocyte-specific nuclear body protein Sp140 in an innate response to human immunodeficiency virus type 1.

Madani N, Millette R, Platt EJ, Marin M, Kozak SL, Bloch DB, Kabat D.

J Virol. 2002 Nov;76(21):11133-8.

13.
14.

Critical role of enhanced CD4 affinity in laboratory adaptation of human immunodeficiency virus type 1.

Platt EJ, Kozak SL, Kabat D.

AIDS Res Hum Retroviruses. 2000 Jun 10;16(9):871-82.

PMID:
10875613
15.
16.
17.

gp120 envelope glycoproteins of human immunodeficiency viruses competitively antagonize signaling by coreceptors CXCR4 and CCR5.

Madani N, Kozak SL, Kavanaugh MP, Kabat D.

Proc Natl Acad Sci U S A. 1998 Jul 7;95(14):8005-10.

19.
20.
21.

Modulation of ecotropic murine retroviruses by N-linked glycosylation of the cell surface receptor/amino acid transporter.

Wang H, Klamo E, Kuhmann SE, Kozak SL, Kavanaugh MP, Kabat D.

J Virol. 1996 Oct;70(10):6884-91.

23.
24.

Amplified and tissue-directed expression of retroviral vectors using ping-pong techniques.

Hoatlin ME, Kozak SL, Spiro C, Kabat D.

J Mol Med (Berl). 1995 Mar;73(3):113-20. Review.

PMID:
7633947
25.

Deletions in one domain of the Friend virus-encoded membrane glycoprotein overcome host range restrictions for erythroleukemia.

Hoatlin ME, Ferro FE Jr, Geib RW, Fox MT, Kozak SL, Kabat D.

J Virol. 1995 Feb;69(2):856-63.

26.

Cell-surface receptors for gibbon ape leukemia virus and amphotropic murine retrovirus are inducible sodium-dependent phosphate symporters.

Kavanaugh MP, Miller DG, Zhang W, Law W, Kozak SL, Kabat D, Miller AD.

Proc Natl Acad Sci U S A. 1994 Jul 19;91(15):7071-5.

27.

A Friend virus mutant encodes a small glycoprotein that causes erythroleukemia.

Hoatlin ME, Ferro FE Jr, Kozak SL, Kabat D.

J Virol. 1994 Jun;68(6):4053-6.

30.
31.

Disulfide bonding controls the processing of retroviral envelope glycoproteins.

Gliniak BC, Kozak SL, Jones RT, Kabat D.

J Biol Chem. 1991 Dec 5;266(34):22991-7.

32.
33.

Activation of erythropoietin receptors by Friend viral gp55 and by erythropoietin and down-modulation by the murine Fv-2r resistance gene.

Hoatlin ME, Kozak SL, Lilly F, Chakraborti A, Kozak CA, Kabat D.

Proc Natl Acad Sci U S A. 1990 Dec;87(24):9985-9.

35.
36.
37.

Extracellular matrix changes PC12 cell shape and processing of newly synthesized dopamine.

Bethea CL, Rønnekleiv OK, Kozak SL.

Mol Cell Endocrinol. 1987 Nov;54(1):63-79.

PMID:
2890544
38.

Further characterization of substratum influence on PC12 cell shape and dopamine processing.

Bethea CL, Kozak SL.

Mol Cell Endocrinol. 1985 Aug;42(1):59-72.

PMID:
4029503
39.

Effect of extracellular matrix on PC 12 cell shape and dopamine processing.

Bethea CL, Kozak SL.

Mol Cell Endocrinol. 1984 Oct;37(3):319-29.

PMID:
6500171

Supplemental Content

Loading ...
Support Center